Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is OrbusNeich Medical Group Holdings Ltd. ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Operating profit has grown by an annual rate -264.92% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Negative results in Jun 25
- ROCE(HY) Lowest at 10.35%
- DEBT-EQUITY RATIO (HY) Highest at -56.92 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.93%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -17.33%, its profits have fallen by -146.2%
4
Below par performance in long term as well as near term
- Along with generating -17.33% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is OrbusNeich Medical Group Holdings Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
OrbusNeich Medical Group Holdings Ltd.
-17.33%
-0.44
43.39%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
20.66%
EBIT Growth (5y)
-264.92%
EBIT to Interest (avg)
12.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.10
Tax Ratio
47.21%
Dividend Payout Ratio
26.65%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.21
EV to EBIT
-20.85
EV to EBITDA
-145.74
EV to Capital Employed
1.49
EV to Sales
11.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.16%
ROE (Latest)
-0.58%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-11What is not working for the Company
ROCE(HY)
Lowest at 10.35%
DEBT-EQUITY RATIO
(HY)
Highest at -56.92 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.93%
RAW MATERIAL COST(Y)
Grown by 6.63% (YoY
CASH AND EQV(HY)
Lowest at HKD 1,861.55 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 22.15 %
PRE-TAX PROFIT(Q)
Lowest at HKD 171.19 MM
Here's what is working for OrbusNeich Medical Group Holdings Ltd.
Depreciation
Highest at HKD 22.49 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 22.49 MM has Grown at 7.56%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for OrbusNeich Medical Group Holdings Ltd.
Debt-Equity Ratio
Highest at -56.92 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 0.93% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Profit Margin
Lowest at 22.15 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at HKD 171.19 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Cash and Eqv
Lowest at HKD 1,861.55 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 6.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






